title: T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma.
authors: Unit of Medical Oncology 2, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian, Milan, Italy. michele.delvecchio@istitutotumori.mi.it
authors: Michele
authors: M
authors: Del Vecchio
authors: Roberta
authors: R
authors: Mortarini
authors: Gabrina
authors: G
authors: Tragni
authors: Lorenza
authors: L
authors: Di Guardo
authors: Ilaria
authors: I
authors: Bersani
authors: Giuseppe
authors: G
authors: Di Tolla
authors: Francesco
authors: F
authors: Agustoni
authors: Valentina
authors: V
authors: Colonna
authors: Jeffrey S
authors: JS
authors: Weber
authors: Andrea
authors: A
authors: Anichini
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors; D006801:Humans; D000074324:Ipilimumab; D008213:Lymphocyte Activation; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000556:secondary; D013601:T-Lymphocytes / Q000276:immunology*; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D060908:CTLA-4 Antigen; D000074324:Ipilimumab